Tempus Ai, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Tempus AI, Inc. announced a significant increase in total revenue to $1.27 billion in 2025, alongside a substantial reduction in net losses and improved adjusted EBITDA, driven by strategic acquisitions and strong growth in its Diagnostics and Data and applications product lines.
NASDAQ
Tempus AI's 10-K filing highlights its commitment to precision medicine through intelligent diagnostics and the application of artificial intelligence in healthcare.